Patent directory · USPTO A61K / A61P
Patents matching “Asana BioSciences, LLC”
35 pharma patents match "Asana BioSciences, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 35 pharmaceutical patents matching "Asana BioSciences, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12077543
P2X3 and/or P2X2/3 compounds and methods
granted -
US 11925629
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted -
US 11434278
Protein-polymer-drug conjugates
granted -
US 11339169
P2X3 and/or P2X2/3 compounds and methods
granted -
US 11103491
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted -
US 10912779
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
granted -
US 10751332
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted -
US 10695296
Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient
granted -
US 10647720
Pyrimido-pyridazinone compounds and methods of use thereof
granted -
US 10611768
P2X3 and/or P2X2/3 compounds and methods
granted -
US 10590127
P2X3 and/or P2X2/3 compounds and methods
granted -
US 10544145
P2X3 and/or P2X2/3 compounds and methods
granted -
US 10471051
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted -
US 10316080
Protein-polymer-drug conjugates
granted -
US 10316039
P2X3 and/or P2X2/3 compounds and methods
granted -
US 10226468
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
granted -
US 10188654
Uses of pyrimido-pyridazinones to treat cancer
granted -
US 10183944
Pyrimido-pyridazinone compounds and methods of use thereof
granted -
US 10174039
P2X3 and/or P2X2/3 compounds and methods
granted -
US 9944637
P2X3 and/or P2X2/3 compounds and methods
granted -
US 9908879
P2X3 and/or P2X2/3 compounds and methods
granted -
US 9757382
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
granted -
US 9533981
Pyridine derivatives
granted -
US 9499495
Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways
granted